[ Theranica raises $6M in Series A ]

Theranica has raised $6 million in Series A funding.

Founded in 2016, Theranica deploys advanced electronics and wireless communication technologies, combined with recent advancements in the research of neurology, to develop a line of “electroceuticals” – drug-free solutions for a few medical conditions, starting with migraine.

The new financing will be used  to complete the regulatory process of Theranica’s first product for acute treatment of migraine and to bring the product to mass production.

Funding  Series A
Founded  2016
Country  Israel
City  Netanya, HaMerkaz
Founder / CEO  Alon Ironi
Deal Size  $6M
Investors  Lightspeed Venture Partners
 Corundum Open Innovations
Previous Investors  Shimon Eckhouse